» Articles » PMID: 25792010

Naturally Occurring Hepatitis B Virus Surface Antigen Mutant Variants in Malaysian Blood Donors and Vaccinees

Overview
Publisher Springer
Date 2015 Mar 21
PMID 25792010
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis B virus surface mutants are of enormous importance because they are capable of escaping detection by serology and can infect both vaccinated and unvaccinated populations, thus putting the whole population at risk. This study aimed to detect and characterise hepatitis B-escaped mutants among blood donors and vaccinees. One thousand serum samples were collected for this study from blood donors and vaccinees. Hepatitis B surface antigen, antibodies and core antibodies were tested using a commercial enzyme-linked immunosorbent assay (ELISA) kit. DNA detection was performed via nested polymerase chain reaction (PCR), and the S gene was sequenced and analysed using bioinformatics. Of the 1,000 samples that were screened, 5.5% (55/1,000) were found to be HBsAg-negative and anti-HBc- and HBV DNA-positive. All 55 isolates were found to belong to genotype B. Several mutations were found across all the sequences from synonymous and non-synonymous mutations, with the most nucleotide mutations occurring at position 342, where adenine was replaced by guanine, and cytosine at position 46 was replaced by adenine in 96.4% and 98% of the isolates, respectively. Mutation at position 16 of the amino acid sequence was found to be common to all the Malaysian isolates, with 85.7% of the mutations occurring outside the major hydrophilic region. This study revealed a prevalence of 5.5% for hepatitis B-escaped mutations among blood donors and vaccinated undergraduates, with the most common mutation being found at position 16, where glutamine was substituted with lysine.

Citing Articles

Molecular Characterization of Hepatitis B Virus in People Living with HIV in Rural and Peri-Urban Communities in Botswana.

Phinius B, Choga W, Anderson M, Mokomane M, Gobe I, Ratsoma T Biomedicines. 2024; 12(7).

PMID: 39062134 PMC: 11275055. DOI: 10.3390/biomedicines12071561.


HBV Vaccines: Advances and Development.

Mahmood F, Xu R, Awan M, Song Y, Han Q, Xia X Vaccines (Basel). 2023; 11(12).

PMID: 38140265 PMC: 10747071. DOI: 10.3390/vaccines11121862.


Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients.

Huong N, Quang Trung N, Luong B, Tram D, Vu H, Bui H PLoS One. 2022; 17(4):e0266134.

PMID: 35390033 PMC: 8989215. DOI: 10.1371/journal.pone.0266134.


Protective and pathogenic role of humoral responses in COVID-19.

Park U, Cho N J Microbiol. 2022; 60(3):268-275.

PMID: 35235178 PMC: 8890013. DOI: 10.1007/s12275-022-2037-8.


Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya.

Aluora P, Muturi M, Gachara G Virol J. 2020; 17(1):176.

PMID: 33187530 PMC: 7666503. DOI: 10.1186/s12985-020-01447-2.


References
1.
Stirk H, Thornton J, Howard C . A topological model for hepatitis B surface antigen. Intervirology. 1992; 33(3):148-58. DOI: 10.1159/000150244. View

2.
Purdy M . Hepatitis B virus S gene escape mutants. Asian J Transfus Sci. 2011; 1(2):62-70. PMC: 3168123. DOI: 10.4103/0973-6247.33445. View

3.
Thun M, DeLancey J, Center M, Jemal A, Ward E . The global burden of cancer: priorities for prevention. Carcinogenesis. 2009; 31(1):100-10. PMC: 2802672. DOI: 10.1093/carcin/bgp263. View

4.
Fang Y, Shang Q, Liu J, Li D, Xu W, Teng X . Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect. 2009; 58(5):383-8. DOI: 10.1016/j.jinf.2009.02.013. View

5.
Ma Q, Wang Y . Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol. 2011; 84(2):198-206. DOI: 10.1002/jmv.23183. View